Intrexon | XON - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Agenus USD 3.19B 3.06B 2026-08
Alaunos Therapeutics USD 7M 2M 2026-03
Amgen USD 209.65B 14.21B 2026-08
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 26.84B 4.19B 2026-08
Karyopharm Therapeutics USD 221M 95M 2026-08
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
MacroGenics USD 184M 82M 2026-03
MannKind USD 1.11B 207M 2026-08
Merck USD 324.18B 6.81B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
Veracyte USD 4.69B 2.12B 2026-06
Xencor USD 1.21B 19M 2026-08